STOCK TITAN

Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2025 financial results on Wednesday, May 7th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, May 7th, at 9:00 a.m. ET.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Investor Relations Contact:

Todd Spencer

Corporate Vice President, Investor Relations

781.222.6455

todd.spencer@crl.com

Source: Charles River Laboratories International, Inc.

FAQ

When will Charles River Laboratories (CRL) report Q1 2025 earnings?

Charles River Laboratories will report Q1 2025 earnings on Wednesday, May 7th, before the market opens.

How can investors access CRL's Q1 2025 earnings call?

Investors can access the live webcast through ir.criver.com at 9:00 a.m. ET on May 7th.

Will there be a replay available for CRL's Q1 2025 earnings call?

Yes, a replay will be accessible through the Investor Relations section at ir.criver.com.

What time is Charles River Laboratories' Q1 2025 earnings call?

The earnings conference call is scheduled for 9:00 a.m. ET on Wednesday, May 7th.
Charles Riv Labs Intl Inc

NYSE:CRL

CRL Rankings

CRL Latest News

CRL Stock Data

5.21B
48.67M
0.94%
106.03%
5.73%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
WILMINGTON